Antitauon Review

In the context of neurodegenerative research, "antitauons" refer to or therapeutic agents designed to neutralize tauons —the prion-like, pathological forms of the tau protein that spread from neuron to neuron. Overview of Tauons and Antitauons

Vaccines that stimulate the patient's own immune system to produce anti-tau antibodies. , ACI-35 Intracellular Targeting antitauon

Using antisense oligonucleotides (ASOs) or "intrabodies" to reduce tau levels within the cell. In the context of neurodegenerative research

Administration of lab-made monoclonal antibodies (mAbs) to target specific tau epitopes. , Semorinemab , Gosuranemab Active Immunotherapy results have been mixed:

While many antitauon therapies have reached clinical trials, results have been mixed: